Advocating for a world where intellectual
property law serves the public interest.
[Dana Brown] Executive Summary: ... Public ownership in pharmaceutical R&D would ensure that more intellectual property related to drug development would be held by public institutions and utilized in the public interest. Right now, a small number of newer medications are responsible for the majority of pharmaceutical spending by public programs like Medicare and Medicaid. Ensuring that new drug development
[Lisa Larrimore Ouellette and Rebecca Weires] Abstract: ... What return does the public receive for the tax dollars spent on R&D, primarily at universities? Does privatizing this research through patent law in fact serve public values? From this social welfare perspective, could the Bayh–Dole framework be improved? In this symposium contribution, we seek to tackle these questions, including by identifying
Copyright laws are beset from every angle. They're criticized for failing to recognize and reward creators, for blocking new forms of creativity, for limiting access to knowledge and for causing culture to be lost. Copyright's fundamental structures were settled before the digital era, but are cemented in by outdated and effectively unamendable treaties. In this public lecture, Associate Professor and
[Clara Ducimetière] In 2009, C.S. Gibson was suggesting that: “With this early coverage of intellectual property in BITs, it is perhaps surprising that there has yet to be a publicly reported decision concerning an IPR-centered investment dispute. Given the trajectory of the modern economy, however, in which foreign investments reflect an increasing concentration of intellectual capital invested in knowledge goods
[International Federation of Library Associations)] After years of IFLA engagement at the World Intellectual Property Organization (WIPO), discussions have reached a key moment. In three regional seminars, many countries asked for international action – a key priority for IFLA. A global conference will take place in October 2019 to make decisions on the way forward.
[Fabian Gaessler, Dietmar Harhoff and Stefan Sorg] Abstract: We investigate the causal effect of patent rights on cumulative innovation, using large-scale data that approximate the patent universe in its technological and economic variety. We introduce a novel instrumental variable for patent invalidation that exploits personnel scarcity in post-grant opposition at the European Patent Office. We find that patent invalidation leads
Posts by Category
- Video
- User Rights Network
- US Domestic Policies
- US Domestic Legislation
- Transparency
- Trade Agreements
- Takedown
- Trade Disputes
- Trademark
- Round-up
- Regional Fora
- Surveys and Data
- Positive Agenda
- Patent Pledges
- Open
- News
- Multilateral Fora
- Limitations and Exceptions
- IP & Research
- IP and Human Rights
- Industry Initiatives
- Flagged
- Fair Use
- Events
- Empirical Research
- Document Library
- Coronavirus
- Brazil
- Blog
- Bilateral Trade Pressures
- Artificial Intelligence
- AI
- Africa Group Work Plan Proposal
- Africa: Copyright & Public Interest
- Access to Medicine
- Academic Resources
